Dataset Information

Hypercholesterolemia interferes with the cardioprotective and hidden cardiotoxic effects of rofecoxib

ABSTRACT: Hypercholesterolemia interferes with the cardioprotective and hidden cardiotoxic effects of rofecoxib

PROVIDER: PRJEB74299 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Dataset's files

Source:

			Action	DRS
	ERR12799100.fastq.gz	Fastqsanger.gz
	ERR12799101.fastq.gz	Fastqsanger.gz
	ERR12799102.fastq.gz	Fastqsanger.gz
	ERR12799103.fastq.gz	Fastqsanger.gz
	ERR12799104.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 96

Similar Datasets

Project description:1.1Background and PurposeHidden cardiotoxicity is defined as drug-induced cardiotoxicity that becomes obvious only in the presence of comorbidities. However, the molecular mechanisms of hidden cardiotoxicity are not always known. Therefore, unbiased multi-omics approaches could assist in revealing regulatory pathways. The most notable representative of hidden cardiotoxic drugs is the cyclooxygenase-2-inhibitor rofecoxib. We previously reported increased mortality in rats due to proarrhythmic effects of rofecoxib on ischemic hearts. Here, we aimed to identify molecular mechanisms of hidden cardiotoxicity exemplified by rofecoxib that present prior to comorbidities.1.2Experimental Approach and Key ResultsRats were treated with rofecoxib or its vehicle for four weeks. RNA sequencing and proteomic datasets of heart samples were used for differential expression and pathway reconstruction analyses. In this model, mechanisms of hidden cardiotoxicity were unable to be revealed by transcriptomic analyses. However, mass-spectrometry-based proteomics showed conspicuous changes, revealing 132 proteins that were dysregulated in expression or on phosphorylation sites. Importantly, the phospho-proteomics allowed us to identify two kinases that may mediate cardiotoxicity. Finally, pathway reconstruction maps a complex molecular machinery whose clustered proteins regulate processes involving cytoskeleton binding, mRNA processing, proteolysis, translation, citrate acid cycle, and calcium ion signalling.1.3Conclusion and ImplicationsThis is the first demonstration that multi-omics characterization can reveal underlying regulatory pathways of hidden cardiotoxicity. Importantly, our study shows that transcriptomics gives limited information on the hidden cardiotoxic effects of rofecoxib, that are mainly mediated by changes in posttranslational modifications and protein expression. These changes, among other mechanisms, may disturb the cardiac calcium handling, which could explain the fatal arrhythmias following ischemia/reperfusion observed with rofecoxib.

Dataset Information

Hypercholesterolemia interferes with the cardioprotective and hidden cardiotoxic effects of rofecoxib

Dataset's files

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets